MTOR and breast carcinoma: Figure 2 shows the effect of the pan-Akt inhibitor MK2206 and the pan-mTOR inhibitor AZD8055 on the growth rate of the breast cancer cell lines MDA-MB-468 and SKBr3 and the colorectal cell line HCT8.